Luca Bolliger, Vice-President and Director Corporate Licensing, Recordati, joins Intellisness Scientific Committee

Grenoble, March 3, 2017 - Luca Bolliger, Vice-President and Director Corporate Licensing, Recordati, joins the Intellisness Scientific Committee. The Intellisness Scientific Committee is comprised of independent representatives from the academic research environment, the pharmaceutical industry and the financial sector. This committee provides a strategic overview combined with insider knowledge on scientific and technological advances, as well as major trends in the market. It advises which themes should be given priority to. The members of this experienced team represent the core values held by Intellisness.
Luca Bolliger studied biochemistry at the ETH in Zürich and completed his undergraduate studies with a Master in Immunology. He graduated at the Biocenter in Basel in biochemistry, and then became Member of the Basel institute for immunology. He then joined the pharmaceutical industry as a Global discovery portfolio manager in the Pharma Strategy Unit at Hoffmann-La Roche Ltd. He then pursued his career in the financial industry as a Fundamental analyst at BT&T asset management, and as a freelance consultant. He established Biopolo Ticino where he also participated in the creation of the Swiss marketing platforms Swiss Biotech and Swiss Medtech before becoming Director Business Development at Actelion. Luca Bolliger joined Recordati from Novimmune where he was director Business Development
“I’m so delighted as Luca joins us. His expertise and creativity are impressive and I’m fully convinced that his contribution will be very positive for the company” says Philippe Fornies, President of Intellisness. “He joins a committee with incredible members, inspired and inspiring. They’re not only experts, they share values of integrity, curiosity and open-mindedness.”
Luca Bolliger commented that “he is honoured to be joining such a distinguished team and he looking forward to an inspiring collaboration”

Intellisness helps its customers to take the best strategic decision by providing high added value information, market research, business insight and intellectual property intelligence services.
The French based company is specialized in Life Sciences and defends a clear bias: a sustainable business in the life sciences industry implies science, market and intellectual property. Taking only one side of this trilogy into account can lead to erroneous conclusions. Intellisness integrates those three dimension to provide best in class tailored services and syndicated reports.
The members of the Scientific Committee are:
Franck Atienzar, Associate Director, Non-clinical development - UCB
Luca Bolliger, VP and Director Corporate Licensing - Recordati
Daniel Christiaen, Director of Research - CNRS, Director of Economic Development – Observatoire Océanologique de Banyuls
Anita Marguerie de Rotrou, Translational Research Program Manager - University of Cambridge
Jacque-Bernard Taste, Founder and President – Biotech & Finances

Intellisness
38560 Jarrie
Philippe Fornies, +33 (0)09 72 57 61 44, contact@intellisness.com, www.intellinsess.com

This release was published on openPR.